Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Remember
-
endoscopy is not necessary for all patients
d
-
endoscopy is safe
b
- though monitor patients who have received midazolam for hypoxia a
Why?
-
Diagnostic endoscopy alone has no clear effect on rebleeding or
mortality
d
so may be avoided in patients who stabilise and do not rebleed.
d
-
Endoscopy is safe in acute gastrointestinal bleeding - perforation, aspiration or bleeding are rare
b
Perforation and aspiration following endoscopy are rare
Complications
b
|
%
(95% CI)
|
NNF
(95% CI)
|
|
perforation
|
0.24%
(0.030% to 0.45%)
|
420
(220 to 3400)
|
|
aspiration
|
0.19%
(0.0040% to 0.38%)
|
520
(270 to 25000)
|
|
haemorrhage
|
0.14%
(0.0% to 0.30%)
|
700
(340 to infinity)
|
|
minor complications
|
0.43%
(0.15% to 0.71%)
|
230
(140 to 670)
|
Midazolam sedation improves tolerance of
gastroscopy in elderly patients but increases the risk of hypoxia
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR
(95% CI) |
NNT
(95% CI) |
elderly inpatient undergoing gastroscopy a  |
midazolam sedation |
placebo |
tolerance of procedure good or very good
at 2 hours |
67% |
41%
(9% to 82%) |
4
(2 to 11) |
| |
|
|
hypoxia
at 2 hours |
18% |
-140%
(-450% to -6%) |
-4
(-28 to -2) |
|